The Levonorgestrel Intrauterine System is an Effective Treatment in Women with Abnormal Uterine Bleeding and Anticoagulant Therapy

Journal of Minimally Invasive Gynecology

Volumn 16, Issue 4, 2009, Pages 480-484

  Vilos, George A ^a,b   Tureanu, Valentin ^a   Garcia, Meivys ^a   Abu Rafea, Basim ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Anticoagulant; LNG IUS; Menorrhagia; Mirena; Thromboprophylaxis; Warfarin

Indexed keywords

LEVONORGESTREL; WARFARIN;

ADENOMYOMA; ADENOMYOSIS; ADULT; AGE DISTRIBUTION; AMENORRHEA; ANTICOAGULANT THERAPY; ARTICLE; BODY MASS; CASE STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMORBIDITY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; LUNG EMBOLISM; MEDICAL RECORD REVIEW; MENOPAUSE; OBESITY; OBSERVATIONAL STUDY; OLIGOMENORRHEA; PAPANICOLAOU TEST; PARITY; PELVIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SPOTTING; STROKE; SURGICAL RISK; THROMBOSIS PREVENTION; UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING; UTERUS MYOMA;

ADULT; ANTICOAGULANTS; CONTRACEPTIVES, ORAL, SYNTHETIC; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; METRORRHAGIA; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; THROMBOSIS; WARFARIN;

EID: 67649365610     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2009.04.018     Document Type: Article

References (22)

1. Vilos G.A., Lefebvre G., and Graves G.R. Guidelines for the management of abnormal uterine bleeding. SOGC Clinical Practice Guidelines No. 106. J Obstet Gynecol Can 23 (2001) 704-709
2. National Collaborating Centre for Women's and Children Health. Heavy Menstrual Bleeding, National Institute for Health and Clinical Excellence (NICE) (2007), Clincal Guidance, London
3. Lasmar R.B., Dias R., Barrozo P.R.M., et al. Prevalence of hysteroscopic findings and histologic diagnosis in patients with abnormal uterine bleeding. Fertil Steril 83 (2008) 1803-1807
4. Luukkainen T., Lahteenmaki P., and Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 22 (1990) 85-90
5. Lahteenmaki P., Rauramo I., and Backman T. The levonorgestrel intrauterine system in contraception. Steroids 65 (2000) 633-637
6. Guttinger A., and Critchley H.D. Endometrial effect of intrauterine levonorgestrel. Contraception 75 (2007) S93-S98
7. Mansour D. Modern management of abnormal uterine bleeding-the levonorgestrel intra-uterine system. Best Pract Res Clin Obstet Gynecol 21 (2007) 1007-1021
8. Varma R., Sinha D., and Gupta J.K. Non-contraceptive uses of levonorgestrel releasing hormone system (LNG-IUS)- A systematic enquiry and overview. Eur J Obstet Gynecol Reprod Biol 125 (2006) 9-28
9. Noncontraceptive uses of the Levonorgestrel Intrauterine System. ACOG Committee Opinion No. 337. Obstet Gynecol 107 (2006) 1479-1482
10. Stewart A., Cummins C., Gold L., Jordan R., and Phillips W. The effectiveness of the levonorgestrel-releasing system in metrorrhagia: a systematic review. Br J Obstet Gynecol 108 (2001) 74-86
11. Roy S.N., and Battacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Safety 27 (2004) 75-90
12. Lethaby A.E., Cooke I., and Rees M. Progesterone or progestogen releasing intrauterine systems for heavy menstrual bleeding (review). Cochrane Database of Systematic Reviews (2005) Issue 4. Art. No.: CD002126. DOT: 10. 1002/14651858. CD002126. pub 2 (Last accessed August 12, 2008)
13. Ellison J., Thompson A.J., and Greer J.A. Apparent interaction between warfarin and levonorgestrel used for emergency contraception. BMJ 321 (2000) 1382
14. Jick S., Kaye J.A., Russmann S., and Jick H. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Contraception 73 (2006) 566-570
15. van Eijkeren M.A., Christiaens G.C., Haspels A.A., and Sixma J.J. Measured menstrual blood loss in women with a bleeding disorder or using anticoagulant therapy. Am J Obstet Gynecol 162 (1990) 1261-1263
16. Kadir R.A., and Chi C. Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy. Contraception 75 (2007) S123-S129
17. Pisoni C.N., Cuadrado M.J., Khamashta M.A., and Hunt B.J. Treatment of menorrhagia associated with oral anticoagulation: efficacy of levonorgestrel releasing intrauterine device. Thromb Res 115 (2005) S121-S122 [Abstract]
18. Pisoni C.N., Cuadrado M.J., Khamashta M.A., and Hunt B.J. Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil). Lupus 15 (2006) 877-880
19. Schaedel Z.E., Dolan G., and Powell M.C. The use of levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders. Am J Obstet Gynecol 193 (2005) 1361-1363
20. Lukes A.S., Reardon B., and Arepally G. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders. Fertil Steril 90 (2008) 673-677
21. Rogovskaya S., Rivera R., Grimes D.A., et al. Effect of levonorgestrel intrauterine system on women with Type I diabetes: a randomized trial. Obstet Gynecol 105 (2005) 811-815
22. Power M.L., Cogswell M.E., and Schulkin J. Obesity prevention and treatment practices of U.S. Obstetrician-Gynecologists. Obstet Gynecol 108 (2006) 961-968